Peter M. Fleischut, MD
Senior Vice President and Chief Transformation Officer
Bio:Peter M. Fleischut, MD, is Senior Vice President and Chief Transformation Officer for NewYork Presbyterian. In this role, he leads NYP’s Epic implementation, Telehealth, Artificial Intelligence, and pharmacy operations. Dr. Fleischut is also responsible for the development of the NYP OnDemand suite of digital health services and the implementation of clinical operations for the new David H. Koch Center at NewYork-Presbyterian/Weill Cornell. A graduate of Jefferson Medical College and the Wharton Program for Working Professionals at the University of Pennsylvania, Dr. Fleischut joined NewYork-Presbyterian Hospital/Weill Cornell in 2006 and has held the roles of Medical Director of the Operating Rooms, Deputy Quality Patient Safety Officer, Founding Director of the Center for Perioperative Outcomes, Vice Chairman, Chief Medical Information Officer, Chief Innovation Officer, and Chief Medical Operating Officer. In 2016, he was appointed Vice Chair of the Department of Anesthesiology at Weill Cornell Medical College, where he is an Assistant Professor of Anesthesiology. Dr. Fleischut has received numerous awards and honors, including NewYork-Presbyterian’s Physician of the Year, Modern Healthcare Up and Comers, Becker’s Hospital Review 40 under 40, and the American Telehealth Association President’s Award.
Anthony Slonim, MD, DrPH, FACHE
President and Chief Executive Officer
Bio:Dr. Anthony Slonim is an innovator and proven leader in health care on both the regional and national levels. During his notable career at major health care organizations and academic institutions, Dr. Slonim has developed a national profile as an expert in patient safety, accountable care, health care quality, and innovative care delivery models focused on improving health within the community. He is an academic leader and tenured professor with more than 100 publications and 15 textbooks to his name. He currently holds appointments as Clinical Professor in the Departments of Internal Medicine and Pediatrics at the University of Nevada, Reno School of Medicine. Since joining Renown Health in July 2014, Dr. Slonim has completely reoriented northern Nevada’s largest locally governed, not-for-profit health care network. He launched a five-year strategic plan that is focused on the community’s overall health while embracing the national Triple Aim initiatives of improving quality care and patient satisfaction — all while reducing costs. Dr. Slonim also ushered in a new era of national collaboration to establish a medical training campus at Renown, expand the region’s quaternary care services in collaboration with Stanford Medicine, and launched the nation’s first-ever community-based, population health study with Desert Research Institute and personal genetics company Helix. While effectively leading and managing the complexity of Renown, Dr. Slonim also manages to serve as Chair-elect on the American Hospital Association’s Systems Council, Board Chair of The Certified Medical Representatives Institute, and was named the inaugural Editor-in-Chief of the Physician Leadership Journal. He is the Board Co-Chair of the Truckee Meadows Healthy Communities and a board member for the Economic Development Authority of Western Nevada.
Luba Greenwood, JD
Strategic Business Development and Corporate Ventures
Bio:Luba brings to Verily pharmaceutical, biotechnology, and digital health industry experience and expertise in building and advising innovative technology companies and providing strategic counsel to global corporations. Previously, Luba has served as Vice President of Global Business Development and Mergers & Acquisitions at Roche, where she also established and led the East Coast Innovation Hub for the Diagnostics Division. Luba is on the Board of MassBio and IRX Therapeutics, and serves as Advisor to Dana-Farber Cancer Institute as part of its Business Development Council. She is also a Lecturer at Boston University Law School and School of Management where she has taught courses in life sciences, business law, innovation, and entrepreneurship since 2014. Luba’s career has spanned leadership roles in venture investing, business development, Mergers & Acquisitions, law, and operations, previously serving as Venture Partner at Colt Ventures; leading BD and Strategy for Pronutria, a Flagship Ventures company; and serving as Senior Mergers & Acquisitions Counsel at Pfizer Inc. Luba began her career practicing law at a leading national law firm, Wilmer Cutler Pickering Hale and Dorr, where she represented clients in securities, IP, regulatory, corporate, and litigation matters. Luba is a recipient of several awards and honors for her work in the community, including the Science Club for Girls Catalyst Award for her commitment to advocating for women in science and technology. Luba served as nonprofit board member of Longwood Symphony Orchestra, Executive Coach for MassNextGen, Co-Chair of MassBio’s Entrepreneur’s University, and mentor and judge for MassCONNECT, MIT 100K Entrepreneurship Competition, and MassChallenge.